Apr 30, 2019 9:50am EDT

22nd Century’s Pre-Market Tobacco Application for VLN™ Cigarettes Advances with Completed FDA Inspection

Apr 18, 2019 1:15pm EDT

Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders

Apr 17, 2019 9:45am EDT

22nd Century Group Hires Former Imperial Brands Head of Regulatory Science

Apr 09, 2019 8:05am EDT

22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis

Mar 28, 2019 9:45am EDT

22nd Century Group Issues Annual Letter to Shareholders

Mar 27, 2019 9:00am EDT

22nd Century’s New Study Confirms Very Low Nicotine Content Cigarettes Result in 97% Less Nicotine in Smoker’s Bloodstream

Mar 06, 2019 4:15pm EST

22nd Century Files 2018 Annual Report and Announces Conference Call to Provide Business Update

Dec 27, 2018 1:02pm EST

22nd Century Files Modified Risk Tobacco Product (MRTP) Application with the FDA for the Company’s Very Low Nicotine Content Cigarettes

Dec 20, 2018 4:49pm EST

22nd Century’s Low-THC Cannabis sativa L. Research Activities Receive Legislative Boost

Dec 05, 2018 9:00am EST

22nd Century Files Premarket Tobacco Application (PMTA) with the FDA